ASSOCIATION ANALYSIS OF 5-HTTLPRVARIANTS, 5-HT_2ARECEPTOR GENE 102T/CPOLYMORPHISM AND MIGRAINE

REFERENCES

• American Psychiatric Association. Diagnostic and Statistical Manual-IV. (1994). American Psychiatric Press, Inc.: Washington, D.C. and London, England. Bagdy, G. (1998). Serotonin, anxiety, and stress hormones. Ann. NY. Acad. Sci. 851, 357–363.
   Google Scholar
• Bagdy, G., & Arato, M. (1998). Gender dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects. Psychopharmacology 136, 342–348.
   Google Scholar
• Bagdy, G., Graf, M., Anhauer, Z.E., Modos, E.A., & Kantor, S. (2001). Anxiety-like effects induced by acute fluoxetine, sertaline or m-CPP treatment are reversed by pre-treatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int. J. Neurophychopharmacol. 4, 399–408.
   PubMed Web of Science ®Google Scholar
• Bagdy, G., Zsombok, T., Gonda, X., & Juhasz, G. (2003). Diagnosis, personality and onset of therapeutical effect of autogenic training may alter headache patient’s compliance. Focus on Alternative and Complementary Medicine (FACT). In press. Breslau, N., & Adreski, P. (1995). Migraine, personality and psychiatric comorbidity. Headache 35, 382–386.
   Google Scholar
• Buchwalder, A., Welch, S.K., & Peroutka, S.J. (1996). Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine. Headache 36, 254–258.
   PubMed Web of Science ®Google Scholar
• Du, L., Bakish, D., & Hrdina, P.D. (2000). Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiat. Genet. 10, 159–164.
   PubMed Web of Science ®Google Scholar
• Du, L., Bakish, D., Lapierre, Y.D., Ravindran, A.V., & Hrdina, P.D. (2000). Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Amer. J. Med. Genet. 96, 56–60.
   PubMed Web of Science ®Google Scholar
• Erdal, E.M., Herken, H., Yilmaz, M., & Bayazit, Y.A. (2001). Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J. Neur. Sci. 188, 99–101.
   Google Scholar
• Fozard, J.R., & Kalkman, H.O. (1994). 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg’s Arch. Pharmacol. 350, 225–229.
   Google Scholar
• Headache Classification Committee of the International Headache Society. (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl. 7), 1–96.
   Google Scholar
• Heils, A., Teufel, A., Petri, S., Stoeber, G., Riederer, P., Bengel, D., & Lesch, K.P. (1996). Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621–2624.
   PubMed Web of Science ®Google Scholar
• Johnson, K.W., Phebus, L.A., & Cohen, M.L. (1998). Serotonin in migraine: Theories, animal models and emerging therapies. Progr. Drug Res. 51, 219–244.
   PubMedGoogle Scholar
• Kotani, K., Shimomura, T., Shimomura, F., Ikawa, S., & Nanba, E. (2002). A poly-morphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 42, 893–895.
   PubMed Web of Science ®Google Scholar
• Lea, R.A., Dohy, A., Jordan, K., Quinlan, S., Brimage, P.J., & Griffiths, L.R. (2000). Evidence for allelic association of the dopamine b-hydroxylase gene (DBH) with sus-ceptibility to typical migraine. Neurogenetics 3, 35–40.
   PubMed Web of Science ®Google Scholar
• Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muler, C.R., Hamer, D.H., & Murphy, D.L. (1996a). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531.
   PubMed Web of Science ®Google Scholar
• Lesch, K.P., Heils, A., & Riederer, P. (1996b). The role of neurotransporters in excito-toxicity, neuronal cell death, and other neurodegenerative processes. J. Molec. Med. 74, 365–378.
   Google Scholar
• Monari, L., Mochi, M., Valentino, M.L., Arnaldi, C., Cortelli, P., De Monte, A., Pierangeli, G., Prologo, G., Scapoli, C., Soriani, S., & Montagna, P. (1997). Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital. J. Neurol. Sci. 18, 277–282.
   Google Scholar
• Montagna, P. (2000). Molecular genetics and migraine. J. Headache Pain. 1, S135–S140.
   Google Scholar
• Nyholt, D.R., Curtain, R.P., Gaffnez, P.T., Brimage, P., Goadsby, P.J., & Griffiths, L.R. (1996). Migraine association and linkage analyses of the human 5-hydroxytryptamine (5-HT2A) receptor gene. Cephalalgia 16, 463–467.
   PubMed Web of Science ®Google Scholar
• Ogilvie,A.D., Russell, M.B., Dhall, P., Battersby, S., Ulrich, V., Smith, C.A., Goodwin, G.M., Harmar, A.J., & Olesen, J. (1998). Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 18, 23–26.
   Google Scholar
• Ophoff, R.A., van den Maagdenberg, A.M.J.M., Roon, K.I., Ferrari, M.D., & Frants, R.R. (2001). The impact of pharmacogenetics for migraine. Eur. J. Pharmacol. 413, 1–10.
   Google Scholar
• Peroutka, S.J. (1998). Serotonin receptor variants in disease: new therapeutic opportunities? Ann. NY. Acad. Sci. 861, 16–25.
   PubMed Web of Science ®Google Scholar
• Silberstein, S.D. (1994). Serotonin and migraine. Headache 34, 408–417.
   PubMed Web of Science ®Google Scholar
• Tajti, J., & Vecsei, L. (2002). Role of antidepressants in the therapy of migraine. Neuro-psychopharmacologica Hungarica IV/1, 21–26.
   Google Scholar
• Veenestra-VanderWeele, J., Anderson, G.M., & Cook, E.H. Jr. (2000). Pharmacogenetics and serotonin system: initial studies and future directions. Eur. J. Pharmacol. 410, 165–181.
   Google Scholar
• Warren, J.T., Peacock, M.L., Rodriguez, L.C., & Fink, J.K. (1993). An MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Molec. Genet. 2, 338.
   PubMedGoogle Scholar
• Yilmaz, M., Erdal, M.E., Herken, H., Cataloluk, O., Barlas, O., & Bayazit, Y.A. (2001). Significance of serotonin transporter gene polymorphism in migraine. J. Neurol. Sci. 186, 27–30.
   PubMed Web of Science ®Google Scholar